Please login to the form below

Not currently logged in
Email:
Password:

Nova appoints Richard Limb as head of quality assurance

He joins the privately-owned company from Pfizer

1198462Leicester, UK-based Nova Laboratories has appointed Richard Limb as its new head of quality assurance in a role that will see him support the overall needs of the business and its technical operations.

Prior to Nova, Limb served Pfizer as its head of quality for its aseptic services division and brings over 20 years’ experience in the healthcare industry.

He said: “The challenge ahead is to support Nova’s growth and expansion plans whilst simultaneously meeting the ever-increasing regulatory demands and expectations in the current market place.

Limb has also worked as a project section leader at 3M Healthcare covering all areas of drug development and commercialisation and significant ‘quality on the floor’ support to manufacturing across a number of roles and organisations.”

“The head of quality assurance is a significant role within Nova and has influence across the business,” said Roger Stainforth, head of group finance.

“He is not in post purely to provide technical excellence and improve our QA systems; these efforts need to be aligned to the strategic direction of the Nova group and support the overall commercial effort whilst ensuring regulatory compliance and best practice across the business units,” he continued.

Limb succeeds Neil Housley who joins Quotient Clinical as its vice president, quality assurance.

17th July 2017

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Healthcare Media Europe – HME Ltd

HME are an innovative and technology enabled agency offering our clients over 35+ years of knowledge and expertise in delivering...

Latest intelligence

No Voice, No Choice
Adelphi Research UK’s insights help to campaign for change in the Mental Health Act...
Island
Pharma’s isolated islands of innovation
With service design and technology often failing the patient, why perspective on improving outcomes need to change...
Uncertainty, austerity and Brexit
What does it mean for the life science sector?...

Infographics